SORTIS Invest advised Lexham Capital Partners, a London-based secondaries fund manager, on the successful GBP 18.65 million (EUR 21.5 million) fundraising for Lexham Special Opportunities I LP, which was completed on 28 August 2025. As part of the transaction, SORTIS Invest introduced and secured participation from Bulgarian investors.
Lexham Special Opportunities I LP is a Guernsey-based investment vehicle focused on acquiring minority stakes in high-quality technology companies through secondary transactions. The Fund acquired minority positions in six technology companies from IP Group, a leading UK-listed investor and developer of innovative technology businesses.
The portfolio companies represent a diversified exposure to clean technology, deep technology, advanced mobility and life sciences:
- Bramble Energy – a UK-based clean technology company developing innovative hydrogen fuel cell systems, focused on cost-efficient, scalable solutions for next-generation energy applications.
- Nexeon – a leading developer of advanced silicon-based anode materials designed to significantly improve the performance and energy density of lithium-ion batteries for electric vehicles and energy storage.
- Oxa Autonomy – a UK-based autonomous driving software company delivering modular, hardware-agnostic autonomy solutions for industrial, logistics and on-road mobility applications.
- Oxford Nanopore Technologies – a London-listed biotechnology company pioneering nanopore-based DNA and RNA sequencing technologies used across research, clinical diagnostics and applied markets, where rapid and accurate genetic analysis delivers direct practical and commercial value.
- Paragraf – a deep-tech company commercialising graphene-based electronic devices using standard semiconductor manufacturing processes for sensors and advanced electronics.
- Tissue Regenix Group – a medical technology company listed on the London Stock Exchange, specialising in regenerative biomaterials and tissue regeneration solutions for orthopaedic, wound care and surgical applications.
Nikolay Georgiev, Partner at Lexham Capital Partners, commented:
“We were very pleased to work with SORTIS Invest on this fundraising. Their strong understanding of investor expectations and their ability to attract high-quality international capital, including investors from Bulgaria, was instrumental to the successful close of Lexham Special Opportunities I LP. We look forward to continuing our collaboration with SORTIS Invest on future fundraising projects.”
The transaction was led by Martin Paev, CFA, Executive Director of SORTIS Invest, who added: “It has been a pleasure to advise Lexham Capital Partners on this successful fundraising. Lexham Special Opportunities I LP provides investors with a compelling opportunity to gain exposure to a high-quality portfolio of innovative technology companies through a well-structured secondary strategy. We are proud to have brought Bulgarian investors into this transaction and look forward to further joint successes with the Lexham team.”
ABOUT LEXHAM CAPITAL PARTNERS
Lexham Capital Partners is a London-based investment manager specialising in secondary and special situation investments, with a focus on acquiring interests in high-quality technology and innovation-driven companies. The firm leverages deep sector expertise and an active portfolio approach to generate attractive risk-adjusted returns for its investors.
ABOUT SORTIS INVEST
SORTIS Invest is an investment banking boutique, based in Sofia, Bulgaria, part of SORTIS Group. It is a member of GlobalScope Partners, a leading global M&A organization with more than 100 offices in 50 countries. Its team of 400+ investment banking professionals has advised more than 10,000 mergers and acquisitions and private equity deals worldwide. SORTIS Invest advises clients on mergers and acquisitions, fundraisings, valuations and financial modelling across a wide range of sectors, including technology, life sciences, energy, industrials and financial services.
